Overview

A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure

Status:
Completed
Trial end date:
2009-08-21
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and tolerability of SK&F-105517-D in japanese patients with chronic heart failure.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Carvedilol